New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Novartis AG
NVSEF
Shape
US Flag

PNK

215B

Drug Manufacturers - General

Next Earning date - 29 Apr 2025

215B

Drug Manufacturers - General

Next Earning date - 29 Apr 2025

110.23USD

0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-100%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

11%

Quote Panel

Shape
Updated March 16, 2025
1W -5.95 % 1M 1.00 % 3M 11.88 % 1Y 9.00 %

Key Metrics

Shape
  • Market Cap

    215.28B


  • Shares Outstanding

    1.98B


  • Share in Float

    1.70B


  • Dividende

    3.95812


  • Earning Date

    29 Apr 2025


  • Price Target

    109


  • Average Volume

    50374


  • Beta

    0.49


  • Range

    90.24-123.55


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.novartis.com


  • Sector

    Healthcare


Fundamentals

Shape

18.54x

P/E Ratio

4.16x

P/S Ratio

4.98x

P/B Ratio

0.7

Debt/Equity

23.1%

Net Margin

$5.9

EPS

How NVSEF compares to sector?

P/E Ratio

Relative Strength

Shape

NVSEF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$53B

Shape289%

2025-Revenue

$8.28

Shape483%

2025-EPS

$19B

Shape258%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-26%

1.08
vs 1.46

Q2.23

arrow
arrow

-29%

1.11
vs 1.56

Q3.23

arrow
arrow

-46%

0.85
vs 1.58

Q4.23

arrow
arrow

+170%

4.11
vs 1.52

Q1.24

arrow
arrow

+21%

1.31
vs 1.08

Q2.24

arrow
arrow

+43%

1.59
vs 1.11

Q3.24

arrow
arrow

+85%

1.57
vs 0.85

Q4.24

arrow
arrow

-66%

1.41
vs 4.11

Q1.25

arrow
arrow

+57%

2.06
vs 1.31

Q2.25

arrow
arrow

+39%

2.22
vs 1.59

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+3%

13.2B  vs 12.8B

Q2.23

arrow
arrow

+7%

13.9B  vs 13.1B

Q3.23

arrow
arrow

-6%

12.1B  vs 12.8B

Q4.23

arrow
arrow

-10%

11.8B  vs 13.1B

Q1.24

arrow
arrow

-13%

11.5B  vs 13.2B

Q2.24

arrow
arrow

-10%

12.6B  vs 13.9B

Q3.24

arrow
arrow

+9%

13.2B  vs 12.1B

Q4.24

arrow
arrow

+15%

13.6B  vs 11.8B

Q1.25

arrow
arrow

+13%

13B  vs 11.5B

Q2.25

arrow
arrow

+9%

13.7B  vs 12.6B

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+4%

0.04
vs 0.02

Q2.23

arrow
arrow

+4%

0.04
vs 0.04

Q3.23

arrow
arrow

+5%

0.05
vs 0.04

Q4.23

arrow
arrow

+18%

0.18
vs 0.05

Q1.24

arrow
arrow

+7%

0.07
vs 0.18

Q2.24

arrow
arrow

+8%

0.08
vs 0.07

Q3.24

arrow
arrow

+7%

0.07
vs 0.08

Q4.24

arrow
arrow

+6%

0.06
vs 0.07

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News